Core Product Advantages

1. Sensitive and Accurate

   Adopts high-precision gene sequencing technology to detect MODY-associated gene variants with high sensitivity and accuracy, ensuring the reliability of test results and laying a solid foundation for the accurate differential diagnosis of MODY.

2. Authoritative Guidance

   Based on authoritative diabetes genetic research evidence and clinical diagnosis guidelines, the test results provide professional and authoritative reference for the differential diagnosis, treatment and medication of MODY, standardizing the clinical management process of the disease.

3. Convenient and Flexible

   Features a streamlined and standardized detection process with simple operation steps from sample processing to sequencing and reporting, and is applicable to a variety of testing scenarios, meeting the diverse genetic testing needs of suspected MODY populations and high-risk groups.

Key Detection Content

Applicable Population

1. People aged ≤ 40 years (mostly adolescents) with negative diabetes autoantibodies
2. People with a significant family history of diabetes
3. Diabetes patients without significant obesity or insulin resistance
4. People with a high-fat, high-calorie diet and lack of exercise
5. People with a history of metabolic diseases
6. Health-conscious individuals who want to screen for MODY genetic risk

Clinical Significance

1. Precise Differential Diagnosis

   Accurately identifies the MODY type of diabetes patients, distinguishes it from other diabetes types, and provides clinicians with the correct diagnostic and treatment direction, avoiding misdiagnosis and reducing unnecessary medical costs.

2. Targeted Treatment and Medication Guidance

   Based on the genetic test results, clinicians can formulate personalized and appropriate treatment plans and medication guidance for MODY patients, improving the effectiveness of disease management.

3. Early Intervention for High-Risk Groups

   Enables early risk warning for asymptomatic family members of MODY patients and other genetic high-risk groups, and guides proactive intervention through diet control and exercise adjustment to prevent the occurrence of diabetes complications.

4. Improve MODY Clinical Management Level

   Effectively raises the clinical awareness rate, diagnosis and treatment rate, and disease control rate of MODY, promoting the standardized and precise management of this specific type of diabetes.

5. Reproductive Risk Early Warning

   For patients with a family history of MODY, the test can predict the risk of their next generation developing the disease in advance, providing a scientific genetic basis for family reproductive health management and genetic counseling.

Standard Detection Process

1. Genomic DNA extraction from clinical samples
2. MODY-associated gene library preparation
3. High-throughput gene sequencing of target loci
4. Professional bioinformatics data analysis and variant identification
5. Formal test report compilation and release

Lead Time